18th Dec 2006 18:29
AGI Therapeutics plc18 December 2006 AGI Therapeutics plc ("AGI" or the "Company") Holdings(s) in Company AGI was notified today that the shareholder notification made to the Company andannounced on 12 December 2006 was incorrect. Following a sale of 250,000 ordinary shares of €0.01 each, Gartmore InvestmentLimited, Gartmore Fund Managers and Gartmore Global Partners have a holding of5.12% of the issued share capital of the Company and not 4.75% as previouslynotified and announced. Contact Information AGI TherapeuticsDavid G. Kelly, Chief Financial Officer Tel: +353 1 449 3254 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai